Back to results
RecruitingPhase 2

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

NCT03412877

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

Contact

NCI SB Immunotherapy Recruitment Center

(866) 820-4505IRC@nih.gov
View on ClinicalTrials.gov
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer — TrialFind